Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder
Condition(s) studied
Investigational drug(s) / intervention(s)
Group-based family cognitive-behavioural therapy: Baseline and post-12 sessions
Waitlist: Baseline and post-12 sessions
Study summary
Obsessive-Compulsive Disorder (OCD) is a common neuropsychiatric illness beginning in childhood. Effective OCD treatments include cognitive-behaviour therapy (CBT) and medications but access to treatment is difficult and does not systematically include parents. The investigators will evaluate clinical and neural effects of Group-based Family CBT (GF-CBT), via a case-control study including: Group 1 - OCD cases receiving GF-CBT (N=90); Group 2 - OCD waitlist cases (N=90). Effects will be measured between baseline and completion of 12 GF-CBT sessions: comparing OCD severity and functioning changes between Groups 1 and 2.
Eligibility
Primary outcome measure(s)
- Children's Yale Brown Obsessive-Compulsive Scale (CY-BOCS) — Baseline, midpoint, completion of 12 GF-CBT sessions, one-month follow-up
CY-BOCS: gold-standard measure of OCD severity in pediatric OCD.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| BC Children's Hospital Research Institute | Vancouver | British Columbia | Recruiting |
More University of British Columbia trials in Canada
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT01635569 on ClinicalTrials.gov ↗ ← All trials in Canada